2024
DOI: 10.1038/s41746-024-01012-z
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson’s disease: a systematic review and meta-analysis

Jing Wang,
Le Xue,
Jiehui Jiang
et al.

Abstract: Artificial intelligence (AI)-assisted PET imaging is emerging as a promising tool for the diagnosis of Parkinson’s disease (PD). We aim to systematically review the diagnostic accuracy of AI-assisted PET in detecting PD. The Ovid MEDLINE, Ovid Embase, Web of Science, and IEEE Xplore databases were systematically searched for related studies that developed an AI algorithm in PET imaging for diagnostic performance from PD and were published by August 17, 2023. Binary diagnostic accuracy data were extracted for m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 59 publications
0
1
0
Order By: Relevance
“…Additionally, AI/ML introduced new approaches in computer-aided detection, assisted interpretation, computer-aided diagnosis [ 13 , 17 , 19 ], as well as for reducing administered dose and radiation exposure to the patient [ 15 ]. From the clinical perspective, AI/ML applications span the entire spectrum of nuclear medicine, with the three main areas being: cardiology for myocardial perfusion imaging and detection of coronary artery disease or prediction of major adverse cardiac events [ 16 , 20 ]; neurology for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and other dementia [ 16 , 21 , 22 ]; and oncology, where it significantly impacted lesion detection and tracking, radiopharmaceutical therapies with precision dosimetry, personalized treatment planning, and therapy response assessment [ 12 , 16 , 19 , 23 ]. AI/ML applications explored new venues in drug discovery, radiopharmacy, and radiochemistry [ 24 ], that greatly enhanced the evolving field of theranostics [ 12 , 23 , 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, AI/ML introduced new approaches in computer-aided detection, assisted interpretation, computer-aided diagnosis [ 13 , 17 , 19 ], as well as for reducing administered dose and radiation exposure to the patient [ 15 ]. From the clinical perspective, AI/ML applications span the entire spectrum of nuclear medicine, with the three main areas being: cardiology for myocardial perfusion imaging and detection of coronary artery disease or prediction of major adverse cardiac events [ 16 , 20 ]; neurology for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and other dementia [ 16 , 21 , 22 ]; and oncology, where it significantly impacted lesion detection and tracking, radiopharmaceutical therapies with precision dosimetry, personalized treatment planning, and therapy response assessment [ 12 , 16 , 19 , 23 ]. AI/ML applications explored new venues in drug discovery, radiopharmacy, and radiochemistry [ 24 ], that greatly enhanced the evolving field of theranostics [ 12 , 23 , 25 ].…”
Section: Introductionmentioning
confidence: 99%